SCHEMBL4317835

SCHEMBL4317835

CS(=O)(=O)C1CCN(c2ccc(N)c(/C=C/c3n[nH]c4ccccc34)c2)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 11/20 0.39
HTR2B P41595 10/20 0.39
AURKA O14965 2/20 0.38
AURKB Q96GD4 2/20 0.38
FGFR1 P11362 4/20 0.37
FLT1 P17948 4/20 0.37
ABL1 P00519 2/20 0.37
PLK4 O00444 2/20 0.37
KDR P35968 2/20 0.37
ITK Q08881 2/20 0.37
BMPR1B O00238 1/20 0.37
STK25 O00506 1/20 0.37
CIT O14578 1/20 0.37
RIOK3 O14730 1/20 0.37
CHEK1 O14757 1/20 0.37
IKBKB O14920 1/20 0.37
GAK O14976 1/20 0.37
DCLK1 O15075 1/20 0.37
CHUK O15111 1/20 0.37
MUSK O15146 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4317837 1.00 HTR6 (0.39) HTR6HTR2BAURKAAURKBFGFR1
SCHEMBL4309001 0.85 AURKA (0.44) HTR6HTR2BAURKAAURKBFGFR1
SCHEMBL4309003 0.85 AURKA (0.44) HTR6HTR2BAURKAAURKBFGFR1
SCHEMBL4313362 0.83 FGFR1 (0.52) HTR6HTR2BAURKAAURKBFGFR1
SCHEMBL4313359 0.83 FGFR1 (0.52) HTR6HTR2BAURKAAURKBFGFR1
SCHEMBL4326946 0.81 FGFR1 (0.53) AURKAAURKBFGFR1FLT1ABL1
SCHEMBL4326947 0.81 FGFR1 (0.53) AURKAAURKBFGFR1FLT1ABL1
SCHEMBL4312073 0.79 FGFR1 (0.41) HTR6HTR2BAURKAAURKBFGFR1
SCHEMBL4312068 0.79 FGFR1 (0.41) HTR6HTR2BAURKAAURKBFGFR1
SCHEMBL4317953 0.78 AURKA (0.53) HTR6HTR2BAURKAAURKBFGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7605272-B2 IGF-1R inhibitor KYOWA HAKKO KIRIN CO., LTD. (JP) 2009-10-20 US disclosed
US-20090054508-A1 IGF-1R INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 US disclosed
EP-1847532-A1 IGF-1R INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-10-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054508-A1 IGF-1R INHIBITOR IGF1R, IGFBP5, IGFBP1 HTR6 928/4885HTR2B 654/4885AURKA 3687/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.